99 research outputs found

    Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down's syndrome

    Get PDF
    OBJECTIVE: To 'map' the current (2004) state of prenatal screening in Europe. DESIGN: (i) Survey of country policies and (ii) analysis of data from EUROCAT (European Surveillance of Congenital Anomalies) population-based congenital anomaly registers. SETTING: Europe. POPULATION: Survey of prenatal screening policies in 18 countries and 1.13 million births in 12 countries in 2002-04. METHODS: (i) Questionnaire on national screening policies and termination of pregnancy for fetal anomaly (TOPFA) laws in 2004. (ii) Analysis of data on prenatal detection and termination for Down's syndrome and neural tube defects (NTDs) using the EUROCAT database. MAIN OUTCOME MEASURES: Existence of national prenatal screening policies, legal gestation limit for TOPFA, prenatal detection and termination rates for Down's syndrome and NTD. RESULTS: Ten of the 18 countries had a national country-wide policy for Down's syndrome screening and 14/18 for structural anomaly scanning. Sixty-eight percent of Down's syndrome cases (range 0-95%) were detected prenatally, of which 88% resulted in termination of pregnancy. Eighty-eight percent (range 25-94%) of cases of NTD were prenatally detected, of which 88% resulted in termination. Countries with a first-trimester screening policy had the highest proportion of prenatally diagnosed Down's syndrome cases. Countries with no official national Down's syndrome screening or structural anomaly scan policy had the lowest proportion of prenatally diagnosed Down's syndrome and NTD cases. Six of the 18 countries had a legal gestational age limit for TOPFA, and in two countries, termination of pregnancy was illegal at any gestation. CONCLUSIONS: There are large differences in screening policies between countries in Europe. These, as well as organisational and cultural factors, are associated with wide country variation in prenatal detection rates for Down's syndrome and NTD

    Parental occupational exposure to endocrine disrupting chemicals and male genital malformations: A study in the danish national birth cohort study

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Sex hormones closely regulate development of the male genital organs during fetal life. The hypothesis that xenobiotics may disrupt endogenous hormonal signalling has received considerable scientific attention, but human evidence is scarce.</p> <p>Objectives</p> <p>We analyse occurrence of hypospadias and cryptorchidism according to maternal and paternal occupational exposure to possible endocrine disrupting chemicals.</p> <p>Methods</p> <p>We conducted a follow-up study of 45,341 male singleton deliveries in the Danish National Birth Cohort during 1997-2009. Information on work during pregnancy was obtained by telephone interviews around gestational week 16. Parents' job titles were classified according to DISCO-88. A job exposure matrix for endocrine disrupting chemicals (EDCs) was implemented to assess occupational exposures. The Medical Birth and National Hospital Register provided data on congenital anomalies diagnosed at birth or during follow-up, which ended in 2009. Crude and adjusted hazard ratios (HR) were obtained from Cox regression models.</p> <p>Results</p> <p>Among all pregnancies, 6.3% were classified as possibly or probably exposed to EDCs. The most prevalent occupations conferring possible exposure were cleaners, laboratory technicians, hairdressers and agricultural workers (58% of all potentially exposed). The final cumulative incidence of cryptorchidism in boys was 2.2% (1002 cases), and of hypospadias 0.6% (262 cases). The occurrence of hypospadias increased when mothers were probably [HRa = 1.8 (95% CI 1.0-2.6)] or possibly exposed to one or more EDCs [HRa = 2.6 (95% CI 1.8-3.4). Possible paternal exposure to heavy metals increased the risk of hypospadias [HRa 2.2 (95% CI: 1.0-3.4)] and cryptorchidism [HRa 1.9 (95% CI: 1.1-2.7)]. None of the exposure groups reached statistical significance.</p> <p>Conclusion</p> <p>The study provides some but limited evidence that occupational exposure to possible endocrine disrupting chemicals during pregnancy increases the risk of hypospadias.</p

    Surveillance of Congenital Anomalies in Europe 1980-1999 : Eurocat Report 8

    No full text

    A review of environmental risk factors for congenital anomalies : special report

    No full text

    An Assessment and Analysis of Surveillance Data on Hypospadias in Europe : special report

    No full text

    EUROCAT – EPIDEMIOLOGICAL SURVEILLANCE OF CONGENITAL ANOMALIES IN EUROPE

    No full text
    Background. European Surveillance of Congenital Anomalies (EUROCAT) is a network of populationbased congenital anomaly registries in Europe surveying more than 1.5 million births per year, or 29% of the births in the European Union. It has been collecting, analysing, and interpreting birth defects surveillance data since 1979. EUROCAT actively monitors major birth defects among infants born to mothers residents in defined European regions. Cases are ascertained from multiple sources, coded using a British Paediatric Association one digit extension, and reviewed and classified by clinical geneticists that take part in the multidisciplinary staff of the network. Epidemiological data on 95 types of congenital anomaly reported among live births, stillbirths, and terminations of pregnancy after prenatal diagnosis are recorded. EUROCAT is monitoring trends and clusters in birth defects and serves for descriptive, risk factor, and prognostic studies of congenital anomalies, including evaluation of neural tube defects prevention strategies related to the periconceptional use of folic acid supplements, and assessment of the impact of the developments of prenatal diagnosis. Conclusions. Congenital anomalies continue to be an important cause of morbidity and mortality in infants and children. The studies on the epidemiological characteristics of congenital defects are limited, because they require the analysis of large populations and a well-organised diagnostic network. Introduction of registries of for the surveillance birth defects enables the assessment of the impact of primary prevention and developments in prenatal screening. The registry can serve as an early warning of teratogen exposures, and act as an information centre regarding clusters, and exposures to risk factors of concern
    corecore